Minoru Oshima

6PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Prognostic Value of the Preoperative Tumor-to-Blood Pool Standardized Uptake Value Ratio Derived From FDG-PET/CT in Distal Bile Duct and Ampullary Cancers.

|Aug 10, 2026
Preoperative Prediction of Pathologic Response After Neoadjuvant Chemoradiotherapy for Pancreatic Ductal Adenocarcinoma: A Metabolic Response-Based Predictive Model.

|Nov 30, 2022
P53 immunolabeling in EUS-FNA biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy.

Minoru Oshima, Keiichi Okano, Hideki Kamada

|Mar 15, 2022
Prediction of local tumor control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy.

Hironobu Suto, Keiichi Okano, Minoru Oshima

|Dec 09, 2021
Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System.

Shinichi Yachida, Yasushi Totoki, Michaël Noë

|Dec 15, 2020
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer.

Minoru Oshima, Keiichi Okano, Hironobu Suto

Pageof 1

Frequent Collaborators

3 joint publications

Hironobu Suto

1 joint publications

Shinichi Yachida

1 joint publications

Yasushi Totoki

1 joint publications

Yoichiro Nakatani